Simultaneous multiple interaction T-cell engaging (SMITE) bispecific antibodies overcome bispecific T-cell engager (BiTE) resistance via CD28 co-stimulation

Leukemia. 2018 May;32(5):1239-1243. doi: 10.1038/s41375-018-0014-3. Epub 2018 Jan 31.

¹ Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
² Hematology/Oncology Fellowship Program, University of Washington, Seattle, WA, USA.
³ Department of Pediatrics, Division of Hematology, University of Washington, Seattle, WA, USA.
⁴ Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. [email protected].
⁵ Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. [email protected].
⁶ Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA. [email protected].
⁷ Department of Epidemiology, University of Washington, Seattle, WA, USA. [email protected].

No abstract available

Publication types